Answers are grounded in this paper and cite their sources.
Risks of ESRD in lupus nephritis improved between the 1970s and the mid-1990s and then plateaued, with an increase in the late 2000s. This pattern suggests limitations in the effectiveness of, or access to, current treatments.
No takes yet. Share an insight, caveat, or question.
Tektonidou et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: